Courtney J Comrie1, Laurel A Dieckhaus1, Tom G Beach2, Geidy E Serrano2, and Elizabeth B Hutchinson1
1Biomedical Engineering, University of Arizona, Tucson, AZ, United States, 2Brain and Body Donation Program, Banner Sun Health Research Institute, Sun City, AZ, United States
Synopsis
Keywords: Alzheimer's Disease, Alzheimer's Disease
Alzheimer’s is an irreversible degenerative brain disease. Clinical MRI may
visualize severe brain atrophy but fails to recognize earlier biomarkers
associated with subtle microstructural changes. Microstructural MRI techniques
such as DTI, MAP-MRI, and MSDKI may sensitively detect and distinguish tissue
degeneration, tauopathies, and beta amyloid plaques in the hippocampus and
entorhinal cortex. The capability of these techniques was investigated in
post-mortem human temporal lobe specimens at high resolution and high image
quality. Prominent findings seen were differences between DTI and MAP-MRI anisotropy
metrics, and striking differences between the hippocampus and entorhinal cortex
for restriction due to plaques.
Introduction
Alzheimer’s Disease (AD)
diagnosis is made based on the presence of hallmark neuropathologies at autopsy 1 and although there has been great progress in development of highly
specific positron emission tomography (PET) markers for amyloid-beta plaques
and neurofibrillary tangles 2, PET is not sensitive to comorbidities 2, and
a need remains for improved non-invasive early diagnosis markers. Current
clinical MRI is capable of reporting severe brain atrophy but fails to
recognize earlier biomarkers associated with subtle cellular and molecular
changes that occur within the hippocampus (HC) and entorhinal cortex (EC). Diffusion
magnetic resonance imaging (dMRI) techniques are promising to address this
challenge and may detect and distinguish tissue degeneration, tauopathies, and
plaques for improved diagnosis accuracy. The study objective was to distinguish
among the most promising dMRI techniques, conventional and advanced, for the
detection of AD pathology in EC and HC exhibiting pathologic changes
sequentially in AD. To accomplish this, we performed dMRI microscopy using
diffusion tensor imaging (DTI), mean apparent propagator (MAP-MRI), and mean
signal diffusion kurtosis imaging (MSDKI) in a set of fourteen post-mortem
temporal lobe specimens and directly analyzed the correlation of quantitative
metrics in the EC and HC with Braak stage, HC/EC plaque score, and HC/EC tangle
score. This quantitative radiologic-pathologic approach was selected to
distinguish among potential markers and to identify trends across the different
techniques for AD influence on water restriction, diffusion, and
micro/macroscale anisotropy.Methods
Fourteen post-mortem human temporal lobe specimens
varying in Braak Stages 3 were received from the Banner Sun Health Brain and
Body Donation Program 4. Two temporal lobe samples of known pathologies,
Braak stage IV AD 4 and healthy, were utilized in the methods development. Eleven
samples were imaged and analyzed for comparative analysis of metrics across
specimens. All samples were prepared according to 4 with short post-mortem
interval, block fixation by paraformaldehyde and rehydration by storage in
saline. Samples were prepared in 50 ml falcon tube and Fluorinert for scanning.
Images were acquired at 250 micron isotropic
resolution using a 7T Bruker Biospec MRI scanner, including multi-shell
diffusion weighted imaging (DWI) 201 DWI volumes over b=0-6,000 s/mm2.
Diffusion pre-processing and DTI and MAP-MRI
calculations were performed using TORTOISE 3.2.0 5-7 to generate fractional
anisotropy (FA), trace (TR), propagator anisotropy maps (PA), return-to-origin
probability (RTOP) among others.
Region of interest (ROI) manual segmentations
were created for eleven HC samples and ten EC samples. Spearman’s correlation
plots (Python) were generated for both EC and HC to identify relationships
between the microstructural metrics and pathological scores. Normalized-averaged
histograms were made after the correlation analysis for a visualization of the
MR metrics behavior for the increasing pathological scorings. HC histograms
were grouped by Braak Scores, while the EC was grouped by plaque count.Results
High-resolution dMRI metric maps were achieved allowing for detailed
visualization of anatomical structures and a clear demonstration that dMRI can
identify regions of pathologic tissue alterations that are absent from
anatomical images (figure 1). Spearman’s correlation in the HC ROIs (figure 2)
revealed strong negative correlation between PA and Braak score (R=-0.68) but
not FA (R=-0.24). However, FA appeared to have a stronger correlation with
Plaques of (R=-0.48). Braak Score correlation differences between FA and PA were
analyzed with averaged histograms (figure 3) where PA had a bimodal
distribution with strong shifts between Braak score groups and FA did not. EC correlations
between plaque count and restrictive metrics (figure 4) RTOP and MSK had values
of 0.57 and 0.3 respectively, decreasing in positive correlations for TR and
MSD in the EC. The restrictive and diffusivity relationships are consistent in
the averaged histogram that was observed in the correlation analysis (figure 5).Discussion
Earlier work identified several potential diffusion metrics associated
with AD pathology and we have extended this work to investigate the correspondence
of diffusivity, restriction, and anisotropy with plaque and tangle scores. Averaged
histograms of FA show a distinct shift towards lower values at higher BRAAK
scores, but little difference is observed between middle and low scores.
However, in PA there a striking shift towards lower values for both middle and high
scores compared to the low. PA also exhibits a bimodal distribution expanding
on the microstructural environment while FA does not. Suggesting PA as more
sensitive than FA to subtle microstructural changes in the HC. Restrictive
metrics, MSK and RTOP, displayed strong negative correlations in the HC paired
with strong positive correlations for diffusivity, however, this relationship
is reversed in the EC. Restriction from plaque count in the EC may be
detectable due advanced neurodegeneration occurring in the earliest stages and
late stages of AD 8, while HC neurodegeneration is less severe early in AD,
allowing degeneration to dominate any restrictive patterns present from
plaques. Conclusion
High quality and resolution data was collected in advanced diffusion
metrics to identify potential early markers of AD. Correlation analysis
suggests that PA can detect plaques and tangles in the hippocampus that are not
detectable by FA. Also, we are sensitive to restriction from plaques in the EC
but not the HC from AD’s degenerative progression. These markers provide
promising new methods towards a reliable and early diagnosis of Alzheimer’s
within the medical field. Acknowledgements
This research was supported by the NIA/NIH grant R03 780250. All imaging
was performed in the UA translational bioimaging resource (TBIR) and made
possible by the NIH small instrumentation grant: S10 OD025016. The authors
would like to thank High Performance Computing (HPC) for providing the
resources needed. Thank you to all the MBSIL members for their support.References
-
Beach TG, Monsell SE, Phillips
LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at
National Institute on Aging Alzheimer Disease Centers, 2005-2010. J
Neuropathol Exp Neurol. 2012 Apr;71(4):266-73.
- Shin J, Lee SY, Kim SH, Kim YB, Cho SJ.
Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in
Alzheimer's disease. Neuroimage. 2008 Nov 1;43(2):236-44. doi:
10.1016/j.neuroimage.2008.07.022. Epub 2008 Jul 23. PMID: 18694837.
- Braak H, Thal DR, Ghebremedhin
E, Del Tredici K. Stages of the pathologic process in alzheimer disease:
Age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011
Nov;70(11):960–9.
- Beach TG, Adler CH, Sue LI,
Serrano G, Shill HA, Walker DG, et al. Arizona Study of Aging and
Neurodegenerative Disorders and Brain and Body Donation Program.
Neuropathology. 2015 Aug 1;35(4):354–89.
- Basser PJ, Mattiello J, LeBihan
D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994
Jan;66(1):259-67. doi: 10.1016/S0006-3495(94)80775-1. PMID: 8130344;
PMCID: PMC1275686.
- Irfanoglu MO, Nayak A, Jenkins
J, Pierpaoli C. TORTOISE v3: Improvements and New Features of the NIH Di.
In: 25th Annual Meeting of the International Society fro Magnetic
Resonance in Medicine. Honolulu, HI; 2017.
- Özarslan E, Guan Koay C,
Shepherd TM, et al. Mean apparent propagator (MAP) MRI: A novel diffusion
imaging method for mapping tissue microstructure. Neuroimage.
2013;78:16-32. doi:10.1016/j.neuroimage.2013.04.016.
- Braak H, Tredici KD, The preclinical phase
of the pathological process underlying sporadic Alzheimer’s disease, Brain, Volume 138, Issue 10,
October 2015, Pages 2814–2833, https://doi.org/10.1093/brain/awv23.